Moderate anemia (8-10 g/dl) was identified in both RA-DMARDs (5 cases) and RA patients treated with anti-TNFα therapy (GOL- 1 case; ADA- 3 cases; ETA- 2 cases). This evidence concerns the gene TNF and anemia (phenotype).